Trial NCT02923531

View at ClinicalTrials.gov 
Org. Study IDs: X4P-001-RCCB

Last trial update was posted on 2022-12-29

MeSH Interventions

Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Clear Cell Renal Cell Carcinoma

Stopping Reasons

Due to low enrollment, the study was terminated early.

Limitations And Caveats

Due to low enrollment, the study was terminated early. Data for some pre-registered endpoints were therefore not collected or analysed and could not be reported.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID